- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 522.01M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $27M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.3B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.05B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $797M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $855M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $17.86B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $17.36B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.45B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.33B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $26.76B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $26.37B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $10.63B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $10.06B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $44.65B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $43.76B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 260M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $208M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $42M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.73 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.74 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $380M |
| Net Income | Q1 2025 · Mar 31, 2024 | $191M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $307M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $710M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.22B |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.93B |